One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...
Global Vaccine Market Size Expected to Reach USD 186.5 Billion by 2032 with 10.7% CAGR - SNS Insider
According to Research by , Vaccine Market Growth is Driven by Increasing Government Support, Technological Innovations, and Growing Demand for Immunization, with Key Contributions from mRNA and ...
CNET3d
Novavax Is Here for the COVID Fight: What to Know About the Vaccine
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
BioWorld3d
Recordati buys rare disease drug Enjaymo in $825M Sanofi deal
Recordati SpA is shelling out $825 million up front for global rights to Enjaymo (sutimlimab), the only therapy approved for treating the rare disease cold agglutinin disease. In the deal with Sanofi ...
US provides $72M to vaccine manufacturers to advance bird flu shot preparedness
There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising ...
ENDPOINTS NEWS4d
BAR­DA doles out $72M to Sanofi, GSK and CSL for bird flu vac­cine sup­ply
The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...